New Moles During and After Pregnancy: What's Normal

Pregnancy raises levels of estrogen, progesterone, and melanocyte-stimulating hormone (MSH). All three increase melanin production. The visible result is the well-known pregnancy hyperpigmentation: darkening of the linea nigra, areolae, nipples, and existing moles. About 90% of pregnant women notice some skin pigmentation change.

In this hormonal environment, existing moles often get slightly darker or larger. Some women develop new pigmented spots that look like moles. Both are common and biologically expected. The challenge is that hormone-driven mole change overlaps superficially with the kind of mole change that signals melanoma — so a routine self-exam during pregnancy needs adjustment for the higher base rate of benign changes.

Common, expected, and benign:

Gradual mild darkening of multiple existing moles, especially on the chest, abdomen, and lower back. Usually all moles change in a similar direction.

New small (1-3mm) light to medium brown spots, often on the abdomen as it stretches.

Slight enlargement of existing moles in proportion to skin stretch (a few millimetres at most).

Stability after delivery — pregnancy-related darkening typically fades partially over 6-12 months postpartum, though it does not always return fully to baseline.

Note: 'in proportion to skin stretch' matters. A mole on the abdomen that grows from 4mm to 5mm as the abdomen expands is consistent with stretch. A mole that grows from 4mm to 8mm and develops asymmetric borders is not.

These are the changes that need dermatology evaluation regardless of pregnancy status:

A single mole that has changed dramatically while others have not. Selective change is more concerning than uniform change.

New asymmetry, irregular borders, or multiple shades of brown/black/red within one mole.

A new mole that is larger than 6mm at first appearance.

Any mole that bleeds, scabs, or fails to heal.

A pigmented streak under a fingernail or toenail.

A non-pigmented raised firm bump that has been growing over weeks (possible amelanotic melanoma).

The red flags are the same as for non-pregnant women, but the threshold to evaluate should be lower in pregnancy because pregnancy melanoma is more difficult to diagnose late.

Pregnancy-associated melanoma (melanoma diagnosed during pregnancy or in the first year postpartum) is rare but real, accounting for about 1 in 1,000 pregnancies. The clinical question that has been studied for decades is whether pregnancy itself worsens melanoma prognosis.

The modern evidence: when matched for stage and tumour thickness at diagnosis, pregnancy-associated melanoma has similar survival to non-pregnancy melanoma. The historical perception that pregnancy 'feeds' melanoma is largely an artefact of later diagnosis (clinicians and patients dismissed mole changes as 'pregnancy normal') and possibly differences in tumour biology that are still being clarified.

The practical implication: pregnancy is not a contraindication to taking mole changes seriously. If anything, the threshold for dermatology evaluation should be slightly lower during pregnancy because the consequences of late diagnosis are higher.

Visual examination and dermoscopy are completely safe in pregnancy — no radiation, no contrast agents, no medications.

Biopsy under local anaesthetic (lidocaine) is also considered safe in pregnancy. Lidocaine has decades of safety data and is a Category B medication. The volumes used for skin biopsy are tiny.

Wide local excision for confirmed melanoma can usually be done with local anaesthetic. Sentinel lymph node biopsy and more extensive surgery may be deferred to after delivery for early-stage disease where short delay does not change outcomes, or done during pregnancy with appropriate anaesthesia for advanced disease.

Systemic therapy (immunotherapy, targeted therapy, chemotherapy) for advanced melanoma in pregnancy is more complex and is decided case-by-case at a specialist centre, weighing maternal benefit against fetal risk.

The practical takeaway: do not avoid dermatology visits because you are pregnant. Most evaluations and many treatments are entirely safe. A worrying mole that is dismissed for 9 months because of pregnancy concerns has had 9 months to grow.

Continue monthly self-exams. Pregnancy is not a reason to skip them. Two adjustments help.

First, photograph more deliberately. The skin is changing rapidly during pregnancy, so memory-based comparison is less reliable. Take photos at the start of each trimester (week 1, week 12, week 24, week 36) and again at 6 weeks postpartum, 6 months postpartum, and 12 months postpartum. These are the natural decision points.

Second, run the ugly-duckling check explicitly. Because many moles change uniformly during pregnancy, the most useful screening method is to look for the mole that is changing differently from the rest. Selective change is the strongest signal.

If you notice a mole that meets ABCDE criteria or is the ugly duckling, book a dermatologist within 1-4 weeks. Do not defer until postpartum.

After delivery, hormone levels drop rapidly. Most pregnancy-induced pigmentation fades partially over 6-12 months. Some persists, particularly melasma on the face and darkened areolae and linea nigra.

Moles that darkened during pregnancy often lighten partially postpartum but rarely return fully to their pre-pregnancy appearance. New moles that appeared during pregnancy typically remain.

The critical postpartum window: 6 weeks to 12 months. Any mole that did not lighten as expected, or that continued to grow or change after delivery when other moles were stabilising, deserves dermatology evaluation. Postpartum is when delayed diagnoses get caught up.

Schedule a dermatologist visit at 6-12 months postpartum if you noticed any pregnancy mole changes, even mild ones. This is not paranoid — it is calibrated to the actual risk profile of the pregnancy-postpartum window.